Sylvie A. Ahn - Concepedia

Author

Sylvie A. Ahn

Cliniques Universitaires Saint-Luc

Also Known As

Bittner, Vera, S A Ahn, SYLVIE A. AHN, Sylvie A Ahn, Sylvie A. Ahn, Sylvie Ahn

138

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Cliniques Universitaires Saint-Luc UCLouvain KU Leuven Centre Hospitalier et Universitaire de Brazzaville Université d'Abomey-Calavi

About

Sylvie A. Ahn is an author at Cliniques Universitaires Saint-Luc specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	25	1.6K
2	Diabetes	10	10	181
3	Public Health	8	8	759
4	Health Sciences	7	7	282
5	Emergency Medicine	1	1	185

Sylvie A. Ahn

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study Philip Jong, Salim Yusuf, Michel F. Rousseau, The Lancet Heart FailureFollow-up StudyCardiovascular DiseaseCardiovascular Pharmacology12-Year Survival	2003	375
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure Michel F. Rousseau, Olivier Gurné, Daniel Duprez, Journal of the American College of Cardiology Heart FailureMedicinePhysiologyBeneficial Neurohormonal ProfilePharmacology	2002	200
Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction Bernhard Gerber, Michel F. Rousseau, Sylvie A. Ahn, Journal of the American College of Cardiology Delayed-enhanced Magnetic ResonanceHeart FailureCardiovascular DiseaseMyocardial InfarctionPrognostic Value	2012	185
Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: The studies of left ventricular dysfunction William J. Rogers, David E. Johnstone, Salim Yusuf, Journal of the American College of Cardiology Quality Of LifeHeart FailureCardiovascular DiseaseLeft Ventricular DysfunctionCardiovascular Pharmacology	1994	158
Additional Prognostic Value of 2D Right Ventricular Speckle-Tracking Strain for Prediction of Survival in Heart Failure and Reduced Ejection Fraction Laura Houard, Marie-Bénédicte Benaets, Christophe de Meester, JACC. Cardiovascular imaging Heart FailureAdditional Prognostic ValueHealth SciencesCardiovascular DiseaseMedical Imaging	2019	110
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor Michel F. Rousseau, Marvin A. Konstam, Claude R. Benedict, The American Journal of Cardiology HypertensionHeart FailureCardiovascular DiseaseMedicineLeft Ventricular Dysfunction	1994	104
Prognostic Impact of Hypertrabeculation and Noncompaction Phenotype in Dilated Cardiomyopathy Mihaela Amzulescu, Michel F. Rousseau, Sylvie A. Ahn, JACC. Cardiovascular imaging Cardiac MuscleCardiomyopathyHeart FailureHealth SciencesCardiovascular Disease	2015	103
Increased Plasma Myostatin in Heart Failure Damien Gruson, Sylvie A. Ahn, Jean‐Marie Ketelslegers, European Journal of Heart Failure	2011	101
The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females Michel P. Hermans, Sylvie A. Ahn, Michel F. Rousseau Lipids in Health and Disease	2012	85
Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence Michel P. Hermans, Frank M. Sacks, Sylvie A. Ahn, Cardiovascular Diabetology	2011	81

Page 1